Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an update

17 May 2016

Abstract excerpt

Frontotemporal lobar degeneration (FTLD) is a spectrum of rare neurodegenerative diseases with overlapping symptoms and neuropathology. It includes the behavioral variant of frontotemporal dementia (bvFTD), the semantic and non-fluent variant of primary progressive aphasia (svPPA and nfvPPA), FTD with motor neuron disease (FTD-MND), progressive supranuclear palsy, and corticobasal syndrome. The diagnosis of the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alzheimer's disease research and treatments
Share to Dementia and Cognitive Impairment Research
Share to Parkinson's Disease Mechanisms and Treatments

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27186717
DOI: 10.1111/jnc.13669

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Neurochemical biomarkers in the diagnosis of frontotemporal lobar degeneration: an updatePMID 27186717Read ↗

Fluid biomarkers in frontotemporal dementia: past, present and futureSemantic proximity Read ↗

Recent advances in understanding frontotemporal degenerationSemantic proximity Read ↗

Biomarkers: a new approach to behavioural variant frontotemporal dementia.Semantic proximity Read ↗

Clinical phenotypes and genetic biomarkers of FTLD.Semantic proximity Read ↗

Blood-Based Biomarkers in Frontotemporal Dementia: A Narrative Review.Semantic proximity Read ↗

Frontotemporal lobar degeneration: current knowledge and future challenges.Semantic proximity Read ↗

Frontotemporal Lobar Degeneration.Semantic proximity Read ↗

Biomarkers in frontotemporal lobar degenerations--progress and challenges.Semantic proximity Read ↗

The past and the future of Alzheimer's disease CSF biomarkers—a journey toward validated biochemical tests covering the whole spectrum of molecular eventsSemantic proximity Read ↗

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers.Semantic proximity Read ↗

Discovery, validation and optimization of cerebrospinal fluid biomarkers for use in Parkinson’s diseaseSemantic proximity Read ↗

[Cerebrospinal fluid markers in early diagnosis of Alzheimer dementia].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.